review of glp 1 GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1-based therapies for diabetes, obesity

Its a situation where we have more questions than answers, said Juliette Cubanski, deputy director of the Medicare policy program at KFF, a nonpartisan health policy research group

But before we go down that path, one of the other things that has come out is that GLP-1s do seem to have other knock-on effects beyond weight loss and beyond diabetes, and so can you talk a little bit about some of the potential of GLP-1s for other health conditions

The smaller design leads to a reduced carbon footprint during the shipping process

At the same time, nearly everyone who comes in for weight loss surgery has already tried a GLP-1

Longer is not better

How GLP-1 Medications Affect Uric Acid and Gout When the body breaks down fat during rapid weight loss, it releases purinescompounds that metabolize into uric acid